Smiths Group has announced the appointment of JehanZeb Noor as chief executive officer of Smiths Medical. JehanZeb will be part of Smiths Group’s executive committee and report to Andy Reynolds Smith, CEO of Smiths Group plc.
He will take up the role on 1 July 2019 and will oversee the separation of Smiths Medical, which is expected to be completed during the first half of 2020.
Andy Reynolds Smith, chief executive of Smiths Group, commented: “I look forward to working with JehanZeb as we continue building a strong, sustainable future for Smiths Medical and progress the separation of the business from Smiths Group. I am confident that JehanZeb’s intimate understanding of the MedTech industry combined with his strong track record of effective leadership, delivering growth and enhanced performance will make him a great success.”
Prior to joining Amcor, JehanZeb was a partner at McKinsey & Company where he served for nine years. He has a deep understanding of the MedTech supply chain, operations, distribution, product development and regulatory approval processes.
JehanZeb holds a BSc in Finance and a BSc and MSc in Mechanical Engineering from the Massachusetts Institute of Technology.
